Case Report

The Use of Coupled Plasma Filtration Adsorption in Traumatic Rhabdomyolysis

Table 1


First treatment
CPFA 10 h
Second treatment
CPFA 10 h
Third treatment
CPFA 10 h
Fourth treatment
CPFA 10 h

Patient 1
Blood flow Qb, mL/min220200200
Total plasma mL7.5007.0007.250
Plasma filtration flow rate, QS%151515
Total dose of heparin I.U.1.2501.2501.250
Reinfusion solution Qinf, mL/min353535
CK value U/L before CPFA14.7909.7636.727
CK value U/L after CPFA10.7257.6592.512
Myoglobin value ng/mL before CPFA7.8813.6251.634
Myoglobin value ng/mL after CPFA4.4121.829823

Patient 2
Blood flow Qb, mL/min250250220220
Total plasma mL9.0008.5008.5008.200
Plasma filtration flow rate, QS%15151515
Total dose of heparin I.U.1.2501.2501.2501.250
Reinfusion solution Qinf, mL/min35353535
CK value U/L before CPFA92.37351.29030.66416.815
CK value U/L after CPFA58.71534.46320.5838.418
Myoglobin value ng/mL before CPFA12.7808.5196.7252.573
Myoglobin value ng/mL after CPFA8.7356.9402.8671.516

Patient 3
Blood flow Qb, mL/min250250250250
Total plasma mL9.0009.0008.5008.500
Plasma filtration flow rate, QS%15151515
Total dose of heparin I.U.1.2501.2501.2501.250
Reinfusion solution Qinf, mL/min35353535
CK value U/L before CPFA79.21662.69158.80632.479
CK value U/L after CPFA65.70859.35439.95618.659
Myoglobin value ng/mL before CPFA12.7578.4266.7313.648
Myoglobin value ng/mL after CPFA9.3286.8693.7133.115

Patient 4
Blood flow Qb, mL/min220200220
Total plasma mL7.5008.0007.200
Plasma filtration flow rate, QS%151515
Total dose of heparin I.U.1.2501.2501.250
Reinfusion solution Qinf, mL/min353535
CK value U/L before CPFA30.38916.49511.699
CK value U/L after CPFA19.36613.8798.933
Myoglobin value ng/mL before CPFA9.5623.8151.318
Myoglobin value ng/mL after CPFA4.2211.752612